We’ve gathered the most frequent questions from our partners and prospects to help you better understand what we do, how we work, and how our technology supports rare disease discovery. Explore the answers below to learn more about Volv Global, our methodology, and our impact.
We’ve grouped the most common questions into key categories to help you quickly find the information that matters to you whether you’re looking to understand our technology, data approach, services, or collaborations.
Volv Global is a healthcare technology company based in Épalinges, Switzerland. We specialise in machine learning to accelerate research and treatment for rare diseases, difficult-to-diagnose diseases and diseases which commonly have delayed diagnosis. Our advanced platform supports medical and commercial stakeholders in pharmaceutical teams by generating novel, data-driven patient and disease insights and real-world evidence.
Volv Global solves key challenges in addressing diagnostic gaps and addressing unmet needs in difficult-to-diagnose diseases and diseases with delayed diagnosis. Our technology analyses vast fragmented datasets to uncover hidden disease patterns, identify undiagnosed patient groups, predict disease outcomes, and enhance precision in clinical and commercial decision-making. The technology also enables stratification of heterogeneous patient populations.
Volv Global’s primary clients are pharmaceutical and biotechnology companies, in particular supporting the work of R&D teams, medical affairs experts, commercial leaders, health economics and outcomes research (HEOR) professionals. In our wider network, we also engage with healthcare providers, research institutions, medical researchers, and patient advocacy organisations globally.
Volv Global is both. As a software platform, we provide a powerful suite of machine learning models and analytical tools called inTrigue, as an end-to-end solution. We deliver insights to clients in role-based interactive analytical dashboards on our inVolv platform. As a service provider, we collaborate with our partners and clients to answer the right questions based on their patient or disease discovery requirements.
No. Volv Global provides technical and machine learning expertise to our clients and in our projects. Our inVolv platform is specifically designed to be intuitive and user-friendly for clients to use without advanced technical expertise or specialised machine learning skills. Volv Global’s specialists provide comprehensive onboarding, continuous training and support for inVolv.
Volv Global analyses structured medical records such as electronic health records (EHRs) or health claims data – all fully anonymised and securely managed – as well as biomedical literature and many other sources, to deliver clinically actionable insights.
Volv Global ensures analytical accuracy and clinical relevance through rigorous validation processes, including cross-validation and real-world validation by medical subject matter experts, ensuring both scientific credibility and clinical utility.
inTrigue is Volv Global’s proprietary machine learning technology in the form of a bespoke collaborative service designed to address complex research challenges. Rather than merely providing tools, inTrigue helps teams rethink medical questions, define new strategic goals, and uncover innovative research paths that conventional methods miss.
Volv Global’s technology platform, inTrigue, utilises a proprietary machine learning engine that learns from extensive biomedical, clinical and claims datasets. inTrigue doesn't just retrieve information – it detects meaningful patterns and generates novel hypotheses, accelerating medical discoveries.
Volv Global’s platform rapidly synthesises biomedical literature, vast quantities of anonymised real-world patient records and claims data to identify novel, testable hypotheses. This significantly accelerates research discovery, clinical trial planning, and market access strategies.
No, Volv Global goes beyond conventional data retrieval. It proactively generates new hypotheses and predictions that traditional search tools cannot, enabling researchers to explore previously unseen connections and possibilities in disease research.
Traditional analytics confirm existing hypotheses, whereas Volv Global’s exploratory models challenge assumptions, uncover hidden relationships, and identify unknown insights, making them uniquely suited to difficult-to-diagnose diseases.
Yes. Researchers have direct access to Volv Global’s intuitive platform interface, inVolv, allowing them to explore data-driven insights, trace the logic of model predictions, and refine analyses for subgroups of interest.
Volv Global’s insights are backed by transparent evidence trails, confidence scoring, external validations, and clinical study comparisons, ensuring robust scientific validity and practical reliability. We collaboratively integrate clients’ feedback and areas of interest in the generated insights.
Yes. The platform integrates the latest published data and research findings at each stage of the project, ensuring models remain cutting-edge and aligned with current scientific advancements. In addition, we monitor changes in the data landscape and refine our models accordingly, as required.
inTrigue is ideal for organisations struggling with difficult to diagnose diseases, dealing with complex, ambiguous research challenges, stuck within traditional processes, or aiming to rapidly accelerate discovery. Each engagement is customised to align with your specific clinical, commercial, and research objectives.
You can initiate an inTrigue conversation by reaching out via our website’s contact form to schedule a discovery meeting. Our process begins with understanding your specific questions and challenges, ensuring tailored support from the outset.
Yes. Volv Global has active international collaborations across North America and Europe. We rigorously uphold global standards for data privacy, ethics, and compliance, making international collaboration seamless and secure.
Volv Global responsibly works with anonymised patient and claims data, which always remains in situ. We always respect the integrity, origin, and privacy standards of all data sources.
Volv Global only works with anonymised patient and claims data, provided by reputable data partners with clear privacy and data security policies. Internally, Volv works with strict access controls and audit trails, protecting data privacy and compliance with regulatory standards.
Yes. Volv Global only works with anonymised data under the data ownership of data partners who fully comply with the required standards of their jurisdiction. In itself, Volv Global follows all relevant data protection laws, and other international regulatory frameworks, maintaining the highest standards for data security, privacy, and ethical compliance.
Ready to shape the future of healthcare? Let’s explore how our machine learning solutions can accelerate diagnoses, refine patient journeys, and drive meaningful impact for those who need it most. We value your ideas and expertise, reach out now to unlock new possibilities together.
